Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis. (May 2022)

Record Type:: Journal Article
Title:: Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis. (May 2022)
Main Title:: Anti-citrullinated protein antibodies dominate the association of long-term outcomes and anti-modified protein antibodies in rheumatoid arthritis
Authors:: van Wesemael, T J
Verstappen, M
Knevel, R
van der Helm-van Mil, A H M
Toes, R E M
van der Woude, D
Abstract:
Is Part Of:: Lancet. Volume 4:Number 5(2022)
Journal:: Lancet
Issue:: Volume 4:Number 5(2022)
Issue Display:: Volume 4, Issue 5 (2022)
Year:: 2022
Volume:: 4
Issue:: 5
Issue Sort Value:: 2022-0004-0005-0000
Page Start:: e316
Page End:: e317
Publication Date:: 2022-05
Subjects:: Rheumatology -- periodicals
616.72305
Journal URLs:: https://www.thelancet.com/journals/lanrhe/issues#decade=loi_decade_201 ↗
https://www.sciencedirect.com/journal/the-lancet-rheumatology ↗
http://www.sciencedirect.com/ ↗
DOI:: 10.1016/S2665-9913(22)00095-9 ↗
Languages:: English
ISSNs:: 2665-9913
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21404.xml